Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Patient Satisfaction 1Patient Preference 1

Interventions

pertuzumab 1pazopanib 1enzalutamide 1delta 24-sterol reductase 1decitabine and cedazuridine drug combination 1daratumumab 1apalutamide 1Validation Studies as Topic 1Trastuzumab 1Tape Recording 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Risk Assessment 1Radiotherapy 1Preoperative Exercise 1Pilot Projects 1Opdualag 1Nutritional Support 1Nivolumab 1Injections, Subcutaneous 1Focus Groups 1Exercise 1Ethanol 1Bandages, Hydrocolloid 1Ado-Trastuzumab Emtansine 1Adiposity 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Patient Preference × Pilot Projects × Clear all
NCT05236218 2023-03-08

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

King's College London

Unknown
60 enrolled

Patient Satisfaction, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡